Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-006521
Filing Date
2013-02-04
Accepted
2013-02-04 19:14:07
Documents
2
Period of Report
2013-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd368543.html 4  
1 FORM 4 rrd368543.xml 4 4722
2 POWER OF ATTORNEY rrd330987_374251.htm EX-24.1 4500
  Complete submission text file 0001181431-13-006521.txt   11336
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEVEL 5 71 COLLINS ST MELBOURNE C3 VIC 3000
Business Address LEVEL 5 71 COLLINS ST MELBOURNE C3 VIC 3000 61386509921
GBS Bioventures II A/C (Reporting) CIK: 0001542843 (see all company filings)

State of Incorp.: C3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 13571611

Mailing Address LEVEL 5 71 COLLINS ST MELBOURNE C3 VIC 3000
Business Address LEVEL 5 71 COLLINS ST MELBOURNE C3 VIC 3000 61386509921
GBS Venture Partners Pty, Ltd (Reporting) CIK: 0001542845 (see all company filings)

State of Incorp.: C3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 13571612